RAG-18
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for RAG-18, covering 2026-01-16 to 2026-01-16. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Tolerability of RAG-18 in Pediatric Patients With Duchenne Muscular Dystrophy [EARLY_Phase 1]